Information for:

Resources

Locke Bryan

Associate Professor

Locke Bryan

Associate Professor

Academic Appointment(s)

Medical College of Georgia
Department of Medicine: Hematology and Oncology

Bio

Internal Medicine Residency, University of Vermont
Chief Residency, University of Vermont
Hematology/Oncology Fellowship, Northwestern University, Chicago, IL. 2012-2015

  • (706) 721-3056
  • (706) 721-5566
  • CN5333

Education

  • MD, Medicine University of Mississippi, 2008

Certifications

  • Hematology ABIM, 2015

  • Medical Oncology ABIM, 2015

  • Internal Medicine ABIM, 2012

  • PHY GA Composite Medical Brd, 2015

  • Georgia Medical License Georgia Composite Medical Board, 2015

Awards & Honors

  • MCG Faculty Exemplary Teaching Award 2020

  • MCG Faculty Exemplary Teaching Award 2019

  • MCG Faculty Exemplary Teaching Award 2018

  • AACR/ASCO Vail Workshop Methods in Clinical Cancer Research, 2014

  • Appointee to American Society of Hematology Trainee Council 2014

Courses Taught Most Recent Academic Year

  • RHON 5000

    Hematology-Oncology

  • RMED 5000

    Medicine

  • PHAS 5227

    Hematology and Oncology

Teaching Interests

Diagnosis and Treatment of Hematologic Malignancies
Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
B cell neoplasms
T cell and natural killer (NK) cell neoplasms
Precursor lymphoid neoplasms
Immunodeficiency-associated lymphoproliferative disorders
Viral mediated lymphomas
Immunotherapy
Novel therapeutics
Bone and marrow transplantation

Scholarship

Selected Recent Publications

  • Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy., 2022
    Journal Article, Academic Journal
  • Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma., 2022
    Journal Article, Academic Journal
  • Leukaemic relapse of anaplastic large cell lymphoma, ALK negative, 2021
    Journal Article, Academic Journal
  • The monocytes that repopulate in mice after cyclophosphamide treatment acquire a neutrophil precursor gene signature and immunosuppressive activity, 2021
    Journal Article, Academic Journal
  • Update on the role of copanlisib in hematologic malignancies., 2021
    Journal Article, Academic Journal

Research Interests

Lymphomas
Immunotherapy
Novel Therapeutics

University Service

  • Appointee, Clinical Performance / Utilization Workgroup Augusta University Health System 2017 - Present

  • Member, Compliance / Audit / Ethics Committee AUMC 2017 - Present

  • Member, Peer Review Committee 2017 - Present

  • Member, Pharmacy and Therapeutics Committee 2017 - Present